# PROMACTA

NDC: 0078-0697
Generic name: eltrombopag olamine
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20180927

FDA application: NDA207027

## Active ingredients

- ELTROMBOPAG OLAMINE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0697"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0697
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7714a0ed-34bb-46e6-a0a5-b363908b22c2